NATIONAL BEVERAGE CORP
FIZZAbout the company
National Beverage Corp., through its subsidiaries, develops, produces, markets, and sells a portfolio of sparkling waters, juices, energy drinks, and carbonated soft drinks in the United States and Canada. The company's Power+ brand portfolio offers sparkling water products under the LaCroix brands; non-carbonated water under the Clear Fruit; energy drink and shots under the Rip It brand; juice and juice-based products under Everfresh, Everfresh Premier Varietals, and Mr. Pure brands; and carbonated soft drinks under Shasta and Faygo brands.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
5 / 8
NEUTRAL / FAIL
Median fair value
$20.20
-45.7% vs price
Models with upside
1 / 17
Positive margin of safety
Strongest signal
5 of 8 pass — Piotroski, Munger and Akre object
Key risk
11 of 12 flag FIZZ's debt & leverage — Graham, Buffett, Lynch +8 more
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | PASS | FAIL | BUY · Rank #257 (Top 8.3%) | NEUTRAL | PASS | PASS | FAIL | FAIL | FAIL | NEUTRAL | FAIL | NEUTRAL | NEUTRAL | FAIL | FAIL | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||
| Margin of Safety | -115.1% | -62.8% | -1707.3% | -93.5% | N/A | -27.5% | -94.5% | -90.9% | +49.1% | N/A | -78.1% | -37.1% | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | TTM ended 2026-08-01 · Balance sheet at 2026-08-01 · Annual history · FY 2025 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-08-01 vs 2025-08-02 · TTM ended 2026-08-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-08-01 · Balance sheet at 2026-08-01 · Market data at 2026-11-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-08-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-08-01 · Market data at 2026-11-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-07-01 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-07-01 Score computed: 2026-11-14 | TTM ended 2026-08-01 · Balance sheet at 2026-08-01 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 · TTM ended 2026-08-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | Annual history · FY 2025 · Balance sheet at 2026-08-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 | TTM ended 2026-08-01 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-09-10 Score computed: 2026-11-14 |
Where It Passes
- Efficiency63% pass✓ 7✗ 4▾
5 of 8 pass — Piotroski, Munger and Akre object
Current Ratio2.39✓Graham>= 2.0ROIC (3-5 yr avg)84.6%✓Buffett> 10%ROIC - WACC+74.6%✓BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)79.2%✓Greenblatt> 25%Current Ratio Change YoY2.90 -> 4.39✓PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.79x -> 1.39x✗PiotroskiImproved YoYCurrent Assets / Current Liabilities2.39✓Dreman> 1.5Return on Invested Capital✗Munger> 15%ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)2/2 years above 12% (latest 39.6%)✓SleepROIC > 12% in a majority of years
Where It Falls Short
- Debt & Leverage8% pass✓ 3✗ 12▾
11 of 12 flag FIZZ's debt & leverage — Graham, Buffett, Lynch +8 more
LT Debt vs Net Current Assets✗GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest Coverage✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity✗Lynch< 0.33Cash - Long-term Debt✗LynchPositive preferredLT Debt / Total Assets Change0.00% -> 0.00%✓PiotroskiDecreased YoYCurrent Assets / Current Liabilities2.39✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00xDebt Levels✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=827.7x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity✗Ackman<= 1.0Negative debt-to-equity (higher means less debt)✗AsnessTop 30% of eligible cross-section - Valuation models10% pass✓ 1✗ 9▾
Models split on FIZZ at $37.23 — fair values range $2.06–$73.15
Graham fair value$17.31✗Graham-115.1% margin vs $37.23Buffett fair value$22.87✗Buffett-62.8% margin vs $37.23Lynch fair value$2.06✗Lynch-1707.3% margin vs $37.23Greenblatt fair value$19.24✗Greenblatt-93.5% margin vs $37.23Dreman fair value$29.20✗Dreman-27.5% margin vs $37.23Munger fair value$19.14✗Munger-94.5% margin vs $37.23Pabrai fair value$19.50✗Pabrai-90.9% margin vs $37.23Akre fair value$73.15✓Akre+49.1% margin vs $37.23Ackman fair value$20.90✗Ackman-78.1% margin vs $37.23Templeton fair value$27.15✗Templeton-37.1% margin vs $37.23 - Valuation15% pass✓ 4✗ 24▾
11 of 13 flag FIZZ's valuation — Graham, Lynch, Greenblatt +8 more
Net income / market capitalization+5.02%; #1683/6340 (top 26.5%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPrice / 3-yr avg EPS19.1x✗Graham<= 15xPrice-to-Book Ratio5.5x✗Graham<= 1.5xP/E x P/B104.80✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)18.04✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise Value7.3%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.3%, ROC=79.2%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS19.0x✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)19.2x✗Dreman< 8xPrice / Book Value per Share5.5x✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessP/E=19.0x, OE Yield=5.2%✓MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldP/E=19.0x, FCF Yield=4.5%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/E=19.0x, P/B=5.5x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-27.5% (IV=$29.20 vs Price=$37.23)✗Marks>= 20% below intrinsic valuePrice / FCF per Share22.3x✓Ackman<= 25Price vs. Trailing Low126% of trailing low ($29.61)✗Templeton<= 120% of trailing low (certified split-adjusted live window)Positive book equity / market capitalization+0.1055; #4713/6449 (top 73.1%)✗AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS19.0x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E0.06✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share5.61x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+78.0%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+0.3388; #3148/5247 (top 60.0%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+4.65%; #1647/4519 (top 36.4%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date+7.26%; #2009/6202 (top 32.4%)✗OshaughnessyTop 10% of eligible cross-section - Growth25% pass✓ 3✗ 10▾
6 of 8 flag FIZZ's growth — Graham, Lynch, Dreman +3 more
EPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)18.04✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR1.1%✓Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 7.0% vs Rev: -1.8%✗LynchInventory growth < Revenue growthEPS Growth Direction✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth0.8%✗Ackman>= 5%Positive EPS Growth Frequency2/5 years with positive EPS growth✗AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR1.1% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 36.0% -> 37.0%, operating margin 18.3% -> 19.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR1.9%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR1.1% over 5 years✗Neff7%-20% annualized - Profitability31% pass✓ 19✗ 16▾
11 of 16 flag FIZZ's profitability — Graham, Buffett, Lynch +8 more
Net income / market capitalization+5.02%; #1683/6340 (top 26.5%)✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive EPS (10 years)17/28 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)✗Graham>= 33% growthNet Income Positive (10+ years)28/28 years positive✓BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)41.4%✓Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)19.5% (latest)✗BuffettStable or rising over 10 yearsFree Cash Flow Proxy$181.2M✓BuffettPositive and growingEarnings Variance (10-yr CoV)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)18.04✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR1.1%✓Lynch15-30% (Fast Grower); > 0% to passROE47.6%✓Lynch> 15%EBIT / Enterprise Value7.3%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=7.3%, ROC=79.2%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets21.56%✓PiotroskiROA > 0ROA Change YoY27.77% -> 21.56% (delta: -6.20%)✗PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=21.28%, ROA=21.56%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY37.0% -> 37.0%✓PiotroskiImproved YoYPre-Tax Income / Revenue19.4%✓Dreman>= 8%Net Income / Shareholders' Equity47.6%✓Dreman> 12%Margin of SafetyP/E=19.0x, P/B=5.5x✗PabraiP/B < 1.5 or P/E < 15Return on Equity34.2% (3-yr avg)✓AkreROE > 20% (3-year avg)Discount to Intrinsic Value-27.5% (IV=$29.20 vs Price=$37.23)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency28/28 years positive✓MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue18.4%✓Ackman>= 15%Net Income / Shareholders Equity47.6%✓Ackman>= 15%5-Year EPS CAGR1.1% CAGR over 5 years✓Templeton> 0% (5-year EPS CAGR)Operating Margin Trend18.3% (2023) -> 19.5% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 36.0% -> 37.0%, operating margin 18.3% -> 19.5%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingGross profit / total assets+73.43%; #306/3702 (top 8.3%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity+47.56%; #224/5226 (top 4.3%)✓AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0437; #2401/5884 (top 40.8%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR1.1% over 5 years✗Neff7%-20% annualizedPositive Diluted-EPS Years10/10 years positive✓Schloss>= 70% positive over 5-10 observed years (app rule) - Verdicts33% pass✓ 4✗ 8▾
Split decision: 8 FAIL · 5 NEUTRAL · 3 PASS
Overall verdict✗GrahamFAIL (2/9)✓BuffettPASS (5/9)✗LynchFAIL (2/7)✓GreenblattRank #257•PiotroskiNEUTRAL (F-Score 6)✓DremanPASS (5/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (2/5)•AckmanNEUTRAL (6/9)✗TempletonFAIL (3/8)•SleepNEUTRAL (4/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked) - Cash Flow50% pass✓ 7✗ 5▾
5 of 10 pass — Lynch, Piotroski, Dreman +2 more object
Free Cash Flow Proxy$181.2M✓BuffettPositive and growingFCF Positive and Growing$161.9M✗LynchPositive and growingOperating Cash Flow$181.3M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=21.28%, ROA=21.56%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)19.2x✗Dreman< 8xP/E or FCF YieldP/E=19.0x, FCF Yield=4.5%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive17/17 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap4.6%✓Ackman>= 4%Price / FCF per Share22.3x✓Ackman<= 25Positive Operating Cash Flow frequency26/26 years positive✓SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$161.9M✓Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization+4.65%; #1647/4519 (top 36.4%)✗OshaughnessyTop 10% of eligible cross-section
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Retired 0.0% of shares last year, 0.0% issued over two.
- Buybacks
- $673.0K
- Dividends
- $0
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.
| Metric | TTM · 2026-08-01 2025-08-03 – 2026-08-01 Sources · derived quarter valuesDerived from cumulative filings: operating cash flow, depreciation amortization, capex, dividends paid, buybacks, revenue, net income, operating income, gross profit, ebit, pre tax income. | Q1 FY 2027 2026-05-03 – 2026-08-01 Sources | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|---|---|
| Market Cap | $3.5Bcurrent | -- | $3.2Best. | $3.9Best. | $4.0Best. | $3.9Best. | $3.9Best. |
| Revenue | $1.2B↓2% | $330.7M | $1.2B↓2% | $1.2B↑1% | $1.2B↑2% | $1.2B↑3% | $1.1B |
| Operating Income | $217.8M↓8% | $58.5M↓17% | $230.1M↓2% | $235.5M↑8% | $218.5M↑17% | $186.7M↓10% | $207.9M |
| Net Income | $174.9M↓6% | $47.0M↓16% | $183.6M↓2% | $186.8M↑6% | $176.7M↑24% | $142.2M↓10% | $158.5M |
| EPS (Diluted) | -- | $0.50↓17% | $1.96↓2% | $1.99↑5% | $1.89↑24% | $1.52↓10% | $1.69 |
| Gross Margin | 36.2%↓3% | 35.0%↓8% | 37.0% | 37.0%↑3% | 36.0%↑6% | 33.8%↓8% | 36.7% |
| Operating Margin | 18.4%↓6% | 17.7%↓17% | 19.5%↓1% | 19.6%↑7% | 18.3%↑15% | 15.9%↓13% | 18.3% |
| ROE | 47.6%↑29% | — | 28.9%↓31% | 42.1%↑33% | 31.6%↓17% | 38.2%↓42% | 66.2% |
| Total Debt | -- | -- | -- | -- | -- | $0↓100% | $30.0M |
| Shareholders' Equity | $367.7M↓27% | $367.7M↓27% | $635.7M↑43% | $444.0M↓21% | $559.5M↑50% | $372.5M↑56% | $239.4M |
| Current Ratio | 2.39↓26% | 2.39↓26% | 4.39↑51% | 2.90↓26% | 3.89↑53% | 2.54↑34% | 1.89 |
| Debt / Equity | — | — | — | — | — | 0.00↓100% | 0.13 |
| Operating Cash Flow | $187.0M↓10% | $64.8M↑10% | $181.3M↓12% | $206.7M↑4% | $197.9M↑22% | $161.7M↑21% | $133.1M |
| Free Cash Flow | $161.9M↓6% | $61.8M↑10% | $156.1M↓8% | $170.4M↑2% | $167.6M↑20% | $139.7M↑34% | $104.1M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Candy & Soda
FIZZ vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monster Beverage CorpMNST | $90.9B | $46.46 | $8.3B | $1.9B | 23.1% | — | 29.2% | 3.70 | 2/9 | 6/9 | 2/7 | 1/3 | F-Score 6 | 6/11 |
| COCA-COLA EUROPACIFIC PARTNERS plcCCEP | $52.0B | $118.57 | $24.6B | $2.3B | 24.8% | 1.30 | 13.4% | 0.80 | 1/9 | 1/9 | 5/7 | 0/3 | F-Score 7 | 3/11 |
| MEXICAN ECONOMIC DEVELOPMENT INCFMX | $44.9B | $131.91 | $37.9B | $2.0B | 13.5% | 0.49 | — | 1.69 | 1/9 | 1/9 | 0/7 | 1/3 | F-Score 4 | 5/11 |
| COCA COLA FEMSA SAB DE CVKOF | $25.3B | $120.63 | $13.6B | $1.2B | 16.5% | 0.50 | — | 1.12 | 1/9 | 0/9 | 1/7 | 1/3 | F-Score 7 | 4/11 |
| Coca-Cola Consolidated, Inc.COKE | $14.3B | $214.34 | $7.2B | $570.6M | -77.1% | -3.77 | 13.2% | 1.26 | 2/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 2/11 |
| Celsius Holdings, Inc.CELH | $8.1B | $32.42 | $2.5B | $108.0M | 9.1% | 0.57 | 5.6% | 1.68 | 2/9 | 2/9 | 4/7 | 1/3 | F-Score 4 | 7/11 |
| ANDINA BOTTLING CO INCAKO-A | $4.0B | $25.29 | $3.7B | $298.6M | 23.2% | — | — | 1.41 | 2/9 | 3/9 | 4/7 | 3/3 | F-Score 7 | 7/11 |
| Zevia PBCZVIA | $78.0M | $1.08 | $161.3M | $9.9M | -19.4% | 0.00 | -7.3% | 2.08 | 2/9 | 1/9 | 2/7 | 0/3 | F-Score 5 | 2/11 |